Redeye leaves its comments on Xspray following a press release confirming that XS003 shows matching ...
EU-lagen CRMA (European Critical Raw Materials Act) har blivit godkänd och gäller från och med mars ...
- Q2'24 results due 22 July - 24e-'26e EBIT revised down 1.
Lipigon has received a milestone payment of USD1m from Leaderna for the approval of a phase I study ...
Förvaltningsresultat ökade med 26% på årsbasis drivet av främst ränteintäkter.
Redeye briefly comments on Enviro’s recent follow-up order for 500 tons of TPO from a leading Europe...
Inför Q2-rapporten räknar Analysguiden med en liknade utvecklingen som i det första kvartalet, med a...
Redeye maintains a positive outlook on Nanologica following its Q2 report.
Redeye comments on Fantasma Games ahead of its Q2 results, due on 7 August.
Redeye comments on Freemelt ahead of its Q2 results, due on 6 August.
Redeye comments on Raketech’s divestment of its US high-touch tipster advisory business as it increa...
- Q2 due Thursday, 18 July, 08:30 CET - We expect lukewarm orders, but a continued high gross margin...
On July 4, after trading closed on Oslo Børs, EG informed Carasent it will not proceed with an offer...
Ahead of Svedbergs Group's Q2 report on 18 July, we expect a decent quarter, with a 1% organic sales...
Q2e: return to growth as comps ease For Q2, we expect sales of SEK 45m, up 10% y-o-y, marking a retu...
Q2e: limited developments In Q2, we expect SEK 279m in order intake, down 2% y-o-y, and sales of SEK...
Q2e: in line with Q1, easy y-o-y comps We expect Q2 sales of SEK 52m, up 26% y-o-y vs.
Cultural and customer similarities bode well Prevas has received regulatory clearance for its acquis...
Redeye comments on Genovis following the announcement of a strategic investment in SEQURNA, a develo...
Solwers’ subsidiary Davidsson Tarkela Architects Oy has today signed an agreement to acquire 100% of...
